Maryam Mokhtarzadeh
Seminars
Tuesday 19th January 2027
Understanding What Investors & Pharma Partners Want to See in Ophthalmic Programs
2:30 pm
This workshop aims to bring together venture investors and pharmaceutical partnering leaders to provide practical guidance on building compelling investment packages and partnership opportunities. Navigate today’s challenging funding landscape by understanding exactly what venture capitalists and pharmaceutical partners evaluate when considering ophthalmic drug delivery investments.
This workshop will gather experts to discuss:
- Learn what data packages, intellectual property positions, and team capabilities pharma partners require for early-stage deals, including insights from companies that have secured partnerships before entering the clinic
- Discover how to position your program to attract investment in an environment where mega-rounds dominate and capital for smaller raises is increasingly scarce
- Gain strategies for demonstrating your technology’s commercial viability, addressing reimbursement considerations, and articulating clear paths to market that resonate with both investors and strategic partners
Wednesday 20th January 2027
Roundtable Discussion: Accelerating Regulatory Approval by Applying Lessons from Successful & Challenged Ophthalmic Programs
4:45 pm
- Learn directly from developers who have navigated approvals, regulatory delays, and setbacks to identify the strategies that improve submission success and reduce risk
- Understand common reasons for complete response letters and how to proactively address these issues in your development plan
- Discuss emerging regulatory considerations for novel modalities including gene therapies, cell therapies, and extended-release implants where precedents are still being established
